10.44PLN-2.97%Mkt Cap: 43.78M PLNP/E: 69.60Last update: 2026-06-01
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and medi…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap43.78M PLN
Enterprise Value59.97M PLN
Revenue (TTM)59.11M PLN
Gross Profit23.26M PLN
Net Income (TTM)535.00K PLN
Revenue/Share14.10 PLN
Last Price10.44 PLN
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees135
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLBIOMX00015
Valuation
P/E (Trailing)69.60
P/E (Forward)—
PEG—
EV/EBITDA12.95
EV/Revenue1.01
P/S0.76
P/B0.96
EPS (TTM)0.15
EPS (Forward)—
52W Range
10.283% of range15.65
52W High15.65 PLN
52W Low10.28 PLN
Profitability
Gross Margin44.01%
Oper. Margin-0.14%
EBITDA Margin7.84%
Profit Margin1.01%
ROE1.13%
ROA0.70%
Growth
Revenue Growth20.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-152.00K PLN
CapEx (TTM)2.27M PLN
FCF Margin18.36%
FCF Yield24.80%
Net Debt14.86M PLN
Net Debt/EBITDA3.21
Balance Sheet
Debt/Equity0.31
Current Ratio1.41
Quick Ratio0.71
Book Value/Sh11.16 PLN
Cash/Share0.2660 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.19M
Float2.69M
Insiders34.41%
Institutions0.00%
Technical
SMA 5011.47 (-9.0%)
SMA 20012.40 (-15.8%)
Beta0.33
S&P 52W Chg27.94%
Avg Vol (30d)3.99K
Avg Vol (10d)4.10K
Technical Indicators
RSI (14)33.6
MACD-0.2009
MACD Signal-0.1772
MACD Hist.-0.0236
BB Upper11.86 PLN
BB Middle11.21 PLN
BB Lower10.56 PLN
BB Width11.59%
ATR (14)0.2713 PLN
Vol Ratio (20d)0.90x